Below are the five companies in the Biotechnology industry with the highest year-over-year expected earnings per share (EPS) growth rates.
Vaccitech plc ranks highest with EPS growth of 4,812.0%. Achilles Therapeutics plc is next with EPS growth of 442.3%. UroGen Pharma Ltd. ranks third highest with EPS growth of 130.4%.
Immutep Limited follows with EPS growth of 109.1%, and Immuron Limited rounds out the top five with EPS growth of 105.5%.
InvestorBrandNetwork is tracking the recent change of momentum in the Industry.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit https://www.InvestorBrandNetwork.com